News from Wolters, Advanced Clinical and BIA – People on the move
Outsourcing-Pharma.com presents its weekly round-up of the latest changes, faces and places in the pharma services sector, including news from Wolters, Advanced Clinical and BIA.
Archives for October 17, 2012
AstraZeneca deal not new for CRL, but still good news
Charles River Laboratories' deal with AstraZeneca may only formalise an existing relationship but a second Big Pharma accord is good news for the CRO say analysts.
Merck Millipore announces 2013 price hike
Merck Millipore has announced plans to increase what it charges for chemical and biopharmaceutical processing solutions, citing rising costs.
Samsung halts biosimilar rituximab trial on regulatory concerns
Reports suggest that Samsung Biologics has halted a trial of a biosimilar version of Roche and Biogen Idec's Rituxan (rituximab).
Ben Venue restarts production; Janssen says Doxil available soon
US CMO Ben Venue has restarted 'limited drug manufacturing' at its plant in Bedford, Ohio, but does not expect to start shipping product for several months.
Disptaches from AAPS
Eliminate scale up by using R&D equipment for commercial production: GSK
Using the same equipment from R&D to scale up will cut costs, time and improve efficiency, according to GSK.
Catalent aims to boost drug delivery through industry-academia partnership
Catalent has established a new institute in a bid to advance drug delivery by creating links between industry and academia.